Pfizer Inc. (NYSE: PFE) today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND® (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of …
Pfizer PFE is one of the largest pharmaceutical companies out there. With a market cap above $200 billion, many may think that the company doesn’t have much more room to grow its share price, but what’s not to love? The company has …
Meanwhile, Dow component Pfizer Inc. (NYSE:PFE) helped boost the blue-chip index higher after ... at 17,832.03; the …
Pfizer (PFE-$36.40) sells drugs, lots of drugs ... His holding company, Berkshire Hathaway, has owned the stock for over 35 years. The $1.48 dividend yields 3.2 percent and should be raised again this year. Procter & Gamble (PG-$90) sells …
In after hours trade shares of Pfizer were up 1.4% following the announcement. Pfizer is set to announce third quarter results on Tuesday, October 28 before the market open. Get the latest Pfizer stock price here.
Pfizer Inc. (NYSE: PFE) shareholders have experienced the short-term euphoria of seeing their stock rally a massive 10 percent from August to September. The stock failed to eclipse key “triple threat” resistance (created by a horizontal line ...
This video takes a closer look at three top blue chip companies which may be in focus for investors this earnings season. After all, with recent risks to the market, investors have been focusing more on blue chips and large caps in general, …
He recently advised us to buy $10,000 worth of the stock. We don't understand what our son-in-law ... you might sell 100 shares of Pfizer and buy 150 shares of RTEC. Pfizer (PFE-$33), among the world's largest and most reputable drug …
NewsOK6mon